Joanna J. Zheng
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Adenosine and Purinergic Signaling, Peptidase Inhibition and Analysis, Vitamin K Research Studies, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Screening and Identification of GSH-Trapped Reactive Metabolites Using Hybrid Triple Quadruple Linear Ion Trap Mass Spectrometry(2007)120 cited
- → Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy(2021)97 cited
- → P2Y6 Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development(2014)89 cited
- → Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y1 Antagonist(2013)69 cited
- → Application and Challenges in Using LC–MS Assays for Absolute Quantitative Analysis of Therapeutic Proteins in Drug Discovery(2014)55 cited
- → Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)(2017)51 cited
- → Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker(2017)39 cited
- → In Silico Prediction of Biliary Excretion of Drugs in Rats Based on Physicochemical Properties(2009)37 cited
- → Comparison of SPE and fast LC to eliminate mass spectrometric matrix effects from microsomal incubation products(2002)34 cited
- → Novel phenylalanine derived diamides as Factor XIa inhibitors(2015)28 cited